Title
Category
Credits
Event date
Cost
  • Primary Care
  • Acute Care
  • Mental Health
  • Pharmacology CE
  • Psychopharmacology CE
  • Contact hours
$15.00
0.75 NAPNAP Pharmacology Contact Hour, and 0.75 Psychopharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 7.5$ for NAPNAP Members. For non- members, this continuing education activity rate is 15$. An extensive review will provide the participant with up-to-date information about commonly used antidepressants and atypical antipsychotics.
  • Primary Care
  • Acute Care
  • Infectious Disease
  • Pharmacology CE
  • Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 10$ for NAPNAP Members. For non- members, this continuing education activity rate is 20$. Current information from CDC will be reviewed. Most current information about vaccine safety will also be covered.
  • Primary Care
  • Acute Care
  • Pharmacology CE
  • Contact hours
$25.00
1.25 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 12$ for NAPNAP Members. For non- members, this continuing education activity rate is 25$. An extensive review will provide the participant with up-to-date information pharmacological management of common respiratory illnesses in children.
  • Primary Care
  • Acute Care
  • Pharmacology CE
  • Contact hours
$15.00
0.75 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 7.5$ for NAPNAP Members. For non- members, this continuing education activity rate is 15$. An extensive review will provide an up‐to‐date information on current recommendations for use of GI drugs in the pharmacological management of common GI pathologies in children.
  • Primary Care
  • Acute Care
  • Pharmacology CE
  • Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 10$ for NAPNAP Members. For non- members, this continuing education activity rate is 20$. An extensive review will provide an up-to-date information on integrating the current evidence regarding the use of supplements in children into primary care pediatric practice.
  • Primary Care
  • Acute Care
  • Infectious Disease
  • Pharmacology CE
  • Contact hours
$25.00
1.25 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 12$ for NAPNAP Members. For non- members, this continuing education activity rate is 25$. This presentation will discuss prescribing for pediatric patients in light of spotlights on inappropriate antibiotic prescribing. A rapid review of current guidelines for treating pediatric infectious diseases will frame a discussion on how to incorporate guidelines into daily practice. Local and national resistance patterns will be discussed, as well as adverse effects of antibiotics including rising resistance and C. difficile rates.
  • Primary Care
  • Acute Care
  • Pharmacology CE
  • Contact hours
$25.00
1.25 NAPNAP Contact Hour, 0.5 Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is 12.5$ for NAPNAP Members. For non- members, this continuing education activity rate is 25$. Cough, both acute and chronic, is one of the most common complaints in the primary and acute care settings. Cough can be stressful and instigate fear and sleepless nights for both children and parents. Early and accurate diagnosis, as well as appropriate therapeutic management, is imperative. This presentation will guide the pediatric focused provider in decision making when diagnosing chronic cough as well as provide a review of current diagnostic testing recommendations and pharmacological updates.
  • Primary Care
  • Pharmacology CE
  • Contact hours
$10.00
1.0 NAPNAP Contact Hour of which 0.25 contain Pharmacology content. This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is $10. Psoriasis, which affects up to 2% of children may be associated with significant comorbidity, including obesity, diabetes, cardiovascular disease, depression, and reduced quality of life. Screening and decision-making require a multidisciplinary approach with the management of potential comorbidities championed by primary care providers and supported by respective specialists and subspecialists. Research into the comorbidities and systemic manifestations has generated significant data culminating in several proposals for a consensus guideline for both pediatric and nonpediatric populations. Our aim is to provide a summary targeted to the pediatric primary care provider from the best available evidence when caring for children with psoriasis. J Pediatr Health Care. (2021) 35, 337−350
  • Primary Care
  • Pharmacology CE
  • Contact hours
$20.00
1.0 NAPNAP Pharmacology Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $10 for NAPNAP Members. For non- members, this continuing education activity rate is $20. Penicillin allergy, the most commonly reported allergy in a pediatric patient, is associated with increases in cost of care, hospitalization and morbidity, as well as contributing to antibiotic resistance. However, 95% of patients labeled with a penicillin allergy do not have a true allergy. The Centers for Disease Control & Prevention has identified improper use of antibiotics to be an important factor that must be addressed for both patient safety and public health. This presentation will identify high-risk symptoms of allergy, differentiate between adverse reactions, IgE-mediated allergic reaction and delayed T-cell reactions, as well as discuss appropriate testing for penicillin allergy. Additionally, the presenter will address alternative antibiotics that can be used until a formal allergy evaluation can be completed.
  • Primary Care
  • Pharmacology CE
  • Psychopharmacology CE
  • Controlled Substances CE
  • Contact hours
$10.00
0.5 contact hour of which 0.5 contain pharmacology content and 0.5 controlled substances.This continuing education activity is offered free to NAPNAP Members. For non- members, this continuing education activity rate is $10. Urine drug screening (UDS) is a laboratory test frequently used to screen for drugs of abuse, monitor for medication compliance, evaluate for suspected drug intoxication or overdose, and in office-based pain contracts (Kale, 2019; Standridge, Adams, & Zotos, 2010). In children and adolescents,UDS may be used to prevent substance use, evaluate for suspected drug use or intoxication, or as part of substance abuse treatment (Levy & Siqueira, 2014). When using UDS as a tool to make clinical decisions about high-risk medications, it is important to understand the differences between UDS testing modalities, common causes of falsepositive or false-negative results, and the detection window of specific medications. There are two commonly used types of UDS available: immunoassay and gas chromatography/ mass spectrometry (GC-MS; Kale, 2019).

Pages